Health-Related Benefits of Nerium Oleander (Guest: Phoenix Biotechnology, Andrew Whitney)
LISTEN to Dr. Tom Roselle, DC and Andrew Whitney, Vice Chairman and Director of Phoenix Biotechnology, Inc. (PBI) discuss the health-related benefits of a novel extract of Nerium oleander.
Phoenix Biotechnology, Inc. (PBI) has developed a supercritical CO2 extraction of Nerium oleander into a new botanical drug – PBI-05204.
PBI-05204 is a ‘botanical drug’ that has been through initial FDA review and approved for the Phase I and Phase II clinical trials which were conducted in the United States. These trials have shown that this oral (capsule) formulation is safe for administration to patients without undue toxicity.
A distinction of PBI-05204 is that research has consistently proven that this drug crosses the blood-brain barrier which opens up several potential applications. Extensive research has been done in the following areas: Antiviral, Cancer, and Neurodegenerative Diseases.
Read more information on PBI-05204 in this article: AN ALL-AMERICAN NATURAL COMPOUND TO CONTEND WITH THE COVID-19 PANDEMIC – A Promising Response to the Coronavirus-2019 Threat
Register for a free health education webinar on WEBINAR: Visualizing Pain Through Thermography on Wednesday, September 16, 2020, at 7 PM. This free webinar will be presented by Derreth Painter, ACCT Thermographer. Call to register at or register ONLINE.
The information provided on Dr. Tom Roselle Live! by Dr. Tom Roselle, DC, PAK, PAc, DCCN, DCBCN, interview guests, show co-hosts, or substitute hosts is not intended nor implied to be a substitute for professional medical advice, diagnosis or treatment; it is for general information purposes only. Information from this broadcast should not replace the appropriate consultation and examination process by a licensed physician. Always consult your own physician prior to changing any current medical directive or prescription.
IF YOU WOULD LIKE TO HAVE DR. TOM ROSELLE LIVE’S PODCAST EMAILED TO YOU WEEKLY, PLEASE SUBSCRIBE HERE.